Vaccination effects on post-infection outcomes in the Omicron BA.2 outbreak in Shanghai

Author:

Wu Qianhui1,Wang Hongyu2,Cai Jianpeng2,Ai Jingwen2,Li Yang2,Zhang Haocheng2,Wang Sen2,Sun Feng2,Wu Yanpeng1,Zhou Jiaxin1,Wang Yan1,Yu Hongjie12,Zhang Wenhong2345

Affiliation:

1. School of Public Health, Fudan University, Key Laboratory of Public Health Safety, Ministry of Education, Shanghai, People’s Republic of China

2. Department of Infectious Disease of Huashan Hospital, National Medical Center for Infectious Diseases and Shanghai Key Laboratory of Infectious Diseases and Biosafety Emergency Response, Fudan University, Shanghai, People’s Republic of China

3. Key Laboratory of Medical Molecular Virology (MOE/MOH) and Institutes of Biomedical Sciences, Shanghai Medical College, Fudan University, Shanghai, People’s Republic of China

4. State Key Laboratory of Genetic Engineering, School of Life Science, Fudan University, Shanghai, People’s Republic of China

5. National Clinical Research Centre for Aging and Medicine, Huashan Hospital, Fudan University, Shanghai, People’s Republic of China

Funder

National Natural Science Foundation of China

Shanghai Municipal Science and Technology Major Project

Shanghai Science and Technology Committee

Publisher

Informa UK Limited

Subject

Virology,Infectious Diseases,Drug Discovery,General Medicine,Immunology,Microbiology,Parasitology,Epidemiology

Reference19 articles.

1. Epidemiological characteristics and transmission dynamics of the outbreak caused by the SARS-CoV-2 Omicron variant in Shanghai, China: A descriptive study

2. Vaccine effectiveness of one, two, and three doses of BNT162b2 and CoronaVac against COVID-19 in Hong Kong: a population-based observational study

3. Shanghai's life-saving efforts against the current omicron wave of the COVID-19 pandemic

4. Commission CNH. Diagnosis and treatment protocol for COVID-19 (trial version 8). 2021. [cited Oct 25 2022]. http://www.gov.cn/zhengce/zhengceku/2021-04/15/content_5599795.htm.

5. Commission CNH. Diagnosis and treatment protocol for COVID-19 (Trial Version 9). 2022. [cited Oct 25 2022]. http://www.gov.cn/zhengce/zhengceku/2022-03/15/content_5679257.htm.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3